Cargando…

Evidence of effective delivery of the human papillomavirus (HPV) vaccine through a publicly funded, school-based program: the Ontario Grade 8 HPV Vaccine Cohort Study

BACKGROUND: Proper administration of the human papillomavirus (HPV) vaccine (three doses at 0, 2, and 6 months) will likely influence the vaccine’s effectiveness and the impact of vaccination programs on health outcomes. Therefore, we assessed HPV vaccine series completion and on-time dosing in Cana...

Descripción completa

Detalles Bibliográficos
Autores principales: Lim, W Ting, Sears, Kim, Smith, Leah M, Liu, Guoyuan, Lévesque, Linda E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4198791/
https://www.ncbi.nlm.nih.gov/pubmed/25278003
http://dx.doi.org/10.1186/1471-2458-14-1029
_version_ 1782339788576129024
author Lim, W Ting
Sears, Kim
Smith, Leah M
Liu, Guoyuan
Lévesque, Linda E
author_facet Lim, W Ting
Sears, Kim
Smith, Leah M
Liu, Guoyuan
Lévesque, Linda E
author_sort Lim, W Ting
collection PubMed
description BACKGROUND: Proper administration of the human papillomavirus (HPV) vaccine (three doses at 0, 2, and 6 months) will likely influence the vaccine’s effectiveness and the impact of vaccination programs on health outcomes. Therefore, we assessed HPV vaccine series completion and on-time dosing in Canada’s largest publicly funded, school-based HPV vaccination program. METHODS: Using administrative health and immunization databases, we identified a population-based cohort of girls eligible for Ontario’s Grade 8 HPV vaccination program in the 2007/08-2009/10 program years who received at least one dose of the vaccine. We determined the number of doses received and calculated the percentage of girls that completed the three-dose series in Grade 8 and Grades 8–9. To assess on-time dosing, the number of days between doses 1–2, 2–3, and 1–3 was calculated and categorized (e.g., too short, on schedule, too long) based on the manufacturer’s recommendations. Analyses were also stratified by program year. RESULTS: We identified a cohort of 55,798 girls who initiated the vaccination series. Series completion was high in the Grade 8 window (81.8%) and increased by approximately 6% in Grade 9. Series completion was similar across the three program years. 70.8%, 98.5%, and 86.1% of girls were classified as ‘on schedule’ for dosing intervals 1–2, 2–3, and 1–3, respectively; 70.0% of girls received all three doses in perfect accordance with dosing recommendations. Stratification revealed that on-time dosing was highest in the first two years of the program (85.6% and 80.6%), but dropped to 42.1% in the 2009/10 year when H1N1 vaccination programs were prioritized. CONCLUSIONS: Our study demonstrates that delivery of the HPV vaccine through a free, school-based program is an effective method of ensuring high completion and on-time dosing, but may not be sufficient to guarantee high coverage.
format Online
Article
Text
id pubmed-4198791
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-41987912014-10-17 Evidence of effective delivery of the human papillomavirus (HPV) vaccine through a publicly funded, school-based program: the Ontario Grade 8 HPV Vaccine Cohort Study Lim, W Ting Sears, Kim Smith, Leah M Liu, Guoyuan Lévesque, Linda E BMC Public Health Research Article BACKGROUND: Proper administration of the human papillomavirus (HPV) vaccine (three doses at 0, 2, and 6 months) will likely influence the vaccine’s effectiveness and the impact of vaccination programs on health outcomes. Therefore, we assessed HPV vaccine series completion and on-time dosing in Canada’s largest publicly funded, school-based HPV vaccination program. METHODS: Using administrative health and immunization databases, we identified a population-based cohort of girls eligible for Ontario’s Grade 8 HPV vaccination program in the 2007/08-2009/10 program years who received at least one dose of the vaccine. We determined the number of doses received and calculated the percentage of girls that completed the three-dose series in Grade 8 and Grades 8–9. To assess on-time dosing, the number of days between doses 1–2, 2–3, and 1–3 was calculated and categorized (e.g., too short, on schedule, too long) based on the manufacturer’s recommendations. Analyses were also stratified by program year. RESULTS: We identified a cohort of 55,798 girls who initiated the vaccination series. Series completion was high in the Grade 8 window (81.8%) and increased by approximately 6% in Grade 9. Series completion was similar across the three program years. 70.8%, 98.5%, and 86.1% of girls were classified as ‘on schedule’ for dosing intervals 1–2, 2–3, and 1–3, respectively; 70.0% of girls received all three doses in perfect accordance with dosing recommendations. Stratification revealed that on-time dosing was highest in the first two years of the program (85.6% and 80.6%), but dropped to 42.1% in the 2009/10 year when H1N1 vaccination programs were prioritized. CONCLUSIONS: Our study demonstrates that delivery of the HPV vaccine through a free, school-based program is an effective method of ensuring high completion and on-time dosing, but may not be sufficient to guarantee high coverage. BioMed Central 2014-10-03 /pmc/articles/PMC4198791/ /pubmed/25278003 http://dx.doi.org/10.1186/1471-2458-14-1029 Text en © Lim et al.; licensee BioMed Central Ltd. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Lim, W Ting
Sears, Kim
Smith, Leah M
Liu, Guoyuan
Lévesque, Linda E
Evidence of effective delivery of the human papillomavirus (HPV) vaccine through a publicly funded, school-based program: the Ontario Grade 8 HPV Vaccine Cohort Study
title Evidence of effective delivery of the human papillomavirus (HPV) vaccine through a publicly funded, school-based program: the Ontario Grade 8 HPV Vaccine Cohort Study
title_full Evidence of effective delivery of the human papillomavirus (HPV) vaccine through a publicly funded, school-based program: the Ontario Grade 8 HPV Vaccine Cohort Study
title_fullStr Evidence of effective delivery of the human papillomavirus (HPV) vaccine through a publicly funded, school-based program: the Ontario Grade 8 HPV Vaccine Cohort Study
title_full_unstemmed Evidence of effective delivery of the human papillomavirus (HPV) vaccine through a publicly funded, school-based program: the Ontario Grade 8 HPV Vaccine Cohort Study
title_short Evidence of effective delivery of the human papillomavirus (HPV) vaccine through a publicly funded, school-based program: the Ontario Grade 8 HPV Vaccine Cohort Study
title_sort evidence of effective delivery of the human papillomavirus (hpv) vaccine through a publicly funded, school-based program: the ontario grade 8 hpv vaccine cohort study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4198791/
https://www.ncbi.nlm.nih.gov/pubmed/25278003
http://dx.doi.org/10.1186/1471-2458-14-1029
work_keys_str_mv AT limwting evidenceofeffectivedeliveryofthehumanpapillomavirushpvvaccinethroughapubliclyfundedschoolbasedprogramtheontariograde8hpvvaccinecohortstudy
AT searskim evidenceofeffectivedeliveryofthehumanpapillomavirushpvvaccinethroughapubliclyfundedschoolbasedprogramtheontariograde8hpvvaccinecohortstudy
AT smithleahm evidenceofeffectivedeliveryofthehumanpapillomavirushpvvaccinethroughapubliclyfundedschoolbasedprogramtheontariograde8hpvvaccinecohortstudy
AT liuguoyuan evidenceofeffectivedeliveryofthehumanpapillomavirushpvvaccinethroughapubliclyfundedschoolbasedprogramtheontariograde8hpvvaccinecohortstudy
AT levesquelindae evidenceofeffectivedeliveryofthehumanpapillomavirushpvvaccinethroughapubliclyfundedschoolbasedprogramtheontariograde8hpvvaccinecohortstudy